Effect of Quench Polish Quench Nitriding Temperature on the Microstructure and Wear Resistance of SAF2906 Duplex Stainless Steel

The effect of quench polish quench (QPQ) nitriding temperature on the microstructure and wear resistance of SAF2906 duplex stainless steel was investigated. Results showed the surface of the nitrided samples was composed of an oxidized layer, a loose compound layer, a compact compound layer, and a diffusion layer. The oxidized layer was composed of Fe3O4. The main phases of the loose compound layer were CrN, alpha(N), Fe2-3N, and Fe3O4. The compact compound layer was composed of CrN, alpha(N), and Fe2-3N. In the diffusion layer, CrN and expanded austenite (S) were the main phases. The nitrided layer thickness increased from 20 to 41 mu m with an increasing temperature of 570 to 610 degrees C. When the nitriding temperature was above 590 degrees C, the precipitates in the diffusion layer became coarsened, and their morphologies gradually changed from spherical particulate to rod-like and flocculent-like. Tribotests showed the cumulative mass loss of QPQ-treated samples was much lower than that of the substrate. The cumulative mass loss of the samples nitrided at 610 degrees C was higher than that at 570 degrees C during the first 29 h. When the test time was over 29 h, the former was lower than the latter

Metabonomics-based omics study and atherosclerosis

Atherosclerosis results from dyslipidemia and systemic inflammation, associated with the strong metabolism and interaction between diet and disease. Strategies based on the global profiling of metabolism would be important to define the mechanisms involved in pathological alterations. Metabonomics is the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification. Metabonomics has been used in combination with proteomics and transcriptomics as the part of a systems biology description to understand the genome interaction with the development of atherosclerosis. The present review describes the application of metabonomics to explore the potential role of metabolic disturbances and inflammation in the initiation and development of atherosclerosis. Metabonomics-based omics study offers a new potential for biomarker discovery by disentangling the impacts of diet, environment and lifestyle

On compression rate of quantum autoencoders: Control design, numerical and experimental realization

Quantum autoencoders which aim at compressing quantum information in a low-dimensional latent space lie in the heart of automatic data compression in the field of quantum information. In this paper, we establish an upper bound of the compression rate for a given quantum autoencoder and present a learning control approach for training the autoencoder to achieve the maximal compression rate. The upper bound of the compression rate is theoretically proven using eigen-decomposition and matrix differentiation, which is determined by the eigenvalues of the density matrix representation of the input states. Numerical results on 2-qubit and 3-qubit systems are presented to demonstrate how to train the quantum autoencoder to achieve the theoretically maximal compression, and the training performance using different machine learning algorithms is compared. Experimental results of a quantum autoencoder using quantum optical systems are illustrated for compressing two 2-qubit states into two 1-qubit states

Effects of caffeine, tea polyphenol and daidzein on the pharmacokinetics of lansoprazole and its metabolites in rats

O objetivo deste estudo foi avaliar os efeitos da cafeína, do polifenol do chá e da daidzeína na farmacocinética do lansoprazol e de seus metabólitos. Administraram-se, intragastricamente, aos ratos cafeína (30 mg·kg-1, uma vez ao dia), polifenol do chá(400 mg·kg-1, uma vez ao dia) ou daidzeína (13,5 mg·kg-1, uma vez ao dia), por 14 dias, seguindo-se a administração de lansoprazol (8 mg·kg-1) no 15º. dia. As concentrações plasmáticas do lansoprazol e de seus dois metabólitos primários, 5-hidroxilansoprazol e sulfona de lansoprazol, foram determinadas por cromatografia líquida de alta eficiência acoplada com espectrometria de massas (CLAE-EM/EM). O polifenol do chá elevou, significativamente, a Área Sob a Curva (ASC) do lansoprazol de 680,29 ± 285,99 para 949,76 ± 155,18 μg/L.h e reduziu a da sulfona de lansoprazol de 268,82 ± 82,37 para 177,72 ± 29,73 μg/L.h. A daidzeína aumentou a ASC do lansoprazol de 680,29 ± 285,99 para 1130,44 ± 97,6 μg/L.h e reduziu a da sulfona de lansoprazol de 268,82 ± 82,37 para 177,72 ± 29,73 μg/L.h. A farmacocinética do 5-hidroxilansoprazol permaneceu intacta na presença de polifenol do chá ou daidzeína. A cafeína não afetou a farmacocinética do lansoprazol e de seus metabólitos. Os resultados sugerem que o polifenol do chá e a daidzeína podem inibir o metabolismo in vivo do lansoprazol por supressão da CYP3A.The aim of this study was to evaluate the effects of caffeine, tea polyphenol and daidzein on the pharmacokinetics of lansoprazole and its metabolites. Rats were intragastrically administered caffeine (30 mg·kg-1, once per day), tea polyphenol (400 mg·kg-1, once per day) or daidzein (13.5 mg·kg-1, once per day) for 14 days, followed by an intragastric administration of lansoprazole (8 mg·kg-1) on the 15th day. The plasma concentrations of lansoprazole and its two primary metabolites, 5-hydroxylansoprazole and lansoprazole sulfone, were determined by high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). Tea polyphenol significantly elevated the Area Under the Curve (AUC) of lansoprazole from 680.29 ± 285.99 to 949.76 ± 155.18 μg/L.h and reduced that of lansoprazole sulfone from 268.82 ± 82.37 to 177.72 ± 29.73 μg/L.h. Daidzein increased the AUC of lansoprazole from 680.29 ± 285.99 to 1130.44 ± 97.6 μg/L.h and decreased that of lansoprazole sulfone from 268.82 ± 82.37 to 116.23 ± 40.14 μg/L.h. The pharmacokinetics of 5-hydroxylansoprazole remained intact in the presence of tea polyphenol or daidzein. Caffeine did not affect the pharmacokinetics of lansoprazole and its metabolites. The results imply that tea polyphenol and daidzein may inhibit the in vivo metabolism of lansoprazole by suppressing CYP3A